RCKT
RCKT
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
4
$269K
Insider Sales
59
$2.14M
Total Volume
$2.41M
91 transactions
Net Activity
$1.87M
Net selling
Sentiment Rating
Moderate AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Heavy distribution: sales represent 89% of total transaction value.
- •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale Insiders
$37.03B total
Shah Gaurav
CEO
$749K total
Wilson Martin
GC
$572K total
Schwartz Jonathan David
See Remarks
$288K total
Patel Kinnari
See Remarks
$238K total
Quick Actions
RCKT has an insider buy conviction of 11%, compared to the Unknown sector buy average of 6%. RCKT ranks #450 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at RCKT (RCKT) engaged in a total of 91 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 59 were sales. The total volume of insider trading reached $2.41M.
The net insider activity for RCKT shows a net selling bias of $1.87M. This activity represents a 11% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.20M shares valued at $23.98B on Apr 10, 2025.
Rocket Pharmaceuticals Stock Price Forecast. Should You Buy RCKT?
RCKT: Rocket Pharmaceuticals officer proposes sale of 2,216 shares
Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going?
Rocket Pharma upgraded at Needham as FDA OKs pivotal trial design
RCKT - Rocket Pharmaceuticals Inc Stock Price and Quote
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus
FAQs About RCKT Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for RCKT.